Free Trial

Ulta Beauty, Inc. (NASDAQ:ULTA) Shares Purchased by Mizuho Securities USA LLC

Ulta Beauty logo with Retail/Wholesale background
Remove Ads

Mizuho Securities USA LLC raised its stake in shares of Ulta Beauty, Inc. (NASDAQ:ULTA - Free Report) by 44.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,465 shares of the specialty retailer's stock after purchasing an additional 1,371 shares during the quarter. Mizuho Securities USA LLC's holdings in Ulta Beauty were worth $1,942,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Geode Capital Management LLC increased its position in shares of Ulta Beauty by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,188,730 shares of the specialty retailer's stock valued at $461,059,000 after acquiring an additional 10,153 shares during the period. Amundi grew its stake in Ulta Beauty by 19.7% during the 4th quarter. Amundi now owns 450,239 shares of the specialty retailer's stock valued at $186,912,000 after purchasing an additional 74,013 shares during the last quarter. Holocene Advisors LP grew its stake in Ulta Beauty by 3,246.2% during the 3rd quarter. Holocene Advisors LP now owns 346,262 shares of the specialty retailer's stock valued at $134,737,000 after purchasing an additional 335,914 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Ulta Beauty by 4.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 319,938 shares of the specialty retailer's stock valued at $139,151,000 after purchasing an additional 12,273 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec raised its stake in shares of Ulta Beauty by 12.2% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 189,310 shares of the specialty retailer's stock worth $73,664,000 after purchasing an additional 20,613 shares during the last quarter. Hedge funds and other institutional investors own 90.39% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Morgan Stanley cut their price target on shares of Ulta Beauty from $500.00 to $460.00 and set an "overweight" rating on the stock in a report on Friday, March 14th. JPMorgan Chase & Co. reduced their target price on shares of Ulta Beauty from $480.00 to $475.00 and set an "overweight" rating for the company in a report on Friday, March 14th. Canaccord Genuity Group lowered their price target on shares of Ulta Beauty from $538.00 to $526.00 and set a "buy" rating on the stock in a report on Friday, March 14th. TD Cowen increased their price target on Ulta Beauty from $450.00 to $480.00 and gave the stock a "hold" rating in a research report on Wednesday, January 8th. Finally, StockNews.com raised Ulta Beauty from a "sell" rating to a "hold" rating in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, Ulta Beauty presently has a consensus rating of "Hold" and an average target price of $427.13.

Check Out Our Latest Report on Ulta Beauty

Ulta Beauty Price Performance

ULTA traded down $1.56 on Thursday, reaching $370.34. 847,825 shares of the company's stock were exchanged, compared to its average volume of 1,045,420. Ulta Beauty, Inc. has a twelve month low of $309.01 and a twelve month high of $529.67. The stock has a market cap of $17.17 billion, a PE ratio of 14.82, a P/E/G ratio of 0.89 and a beta of 1.34. The stock's fifty day moving average price is $374.58 and its 200-day moving average price is $386.37.

Ulta Beauty (NASDAQ:ULTA - Get Free Report) last posted its earnings results on Thursday, March 13th. The specialty retailer reported $8.46 earnings per share for the quarter, beating the consensus estimate of $7.13 by $1.33. The company had revenue of $3.49 billion for the quarter, compared to analyst estimates of $3.47 billion. Ulta Beauty had a net margin of 10.58% and a return on equity of 51.95%. Ulta Beauty's revenue was down 1.9% on a year-over-year basis. During the same period in the previous year, the business posted $8.08 EPS. As a group, research analysts predict that Ulta Beauty, Inc. will post 23.96 earnings per share for the current fiscal year.

About Ulta Beauty

(Free Report)

Ulta Beauty, Inc operates as a specialty beauty retailer in the United States. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications.

Recommended Stories

Institutional Ownership by Quarter for Ulta Beauty (NASDAQ:ULTA)

Should You Invest $1,000 in Ulta Beauty Right Now?

Before you consider Ulta Beauty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ulta Beauty wasn't on the list.

While Ulta Beauty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

The Future of Healthcare: 3 AI Stocks Leading the Way

The Future of Healthcare: 3 AI Stocks Leading the Way

2025 promises explosive growth for AI, but which companies are making a difference in healthcare? Chris Markoch highlights three stocks leading the charge.

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads